DDInter 2.0: an enhanced drug interaction resource with expanded data coverage, new interaction types, and improved user interface
Nucleic Acids Research · 06.01.2025 · 53 (D1) · D1356-D1362
DOI: 10.1093/nar/gkae726 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 24.08.2024. Verfasst von Yao Tian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, P.R. China. Hauptthemen laut MEDLINE: Drug Interactions, User-Computer Interface. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Hunan Provincial Science Fund for Distinguished Young Scholars.
Abstract (Originalsprache)
Drug interactions pose significant challenges in clinical practice, potentially leading to adverse drug reactions, reduced efficacy, and even life-threatening consequences. As polypharmacy becomes increasingly common, the risk of harmful drug interactions rises, underscoring the need for comprehensive and user-friendly drug interaction resources to ensure patient safety. To address these concerns and support healthcare professionals in optimizing drug therapy, we present DDInter 2.0, a significantly expanded and enhanced update to our drug interaction database. This new version incorporates additional interaction types, including drug-food interactions (DFIs), drug-disease interactions (DDSIs), and therapeutic duplications, providing a more complete resource for clinical decision-making. The updated database covers 2310 drugs, with 302 516 drug–drug interaction (DDI) records accompanied by 8398 distinct, high-quality mechanism descriptions and management recommendations. DDInter 2.0 also includes 857 DFIs, 8359 DDSIs and 6033 therapeutic duplication records, each supplemented with detailed information and guidance. Furthermore, the enhanced user interface and advanced filtering options in this second release facilitate easy access to and analysis of the comprehensive drug interaction data. By providing healthcare professionals and researchers with a more complete and user-friendly resource, DDInter 2.0 aims to support clinical decision-making and ultimately improve patient outcomes. DDInter 2.0 is freely accessible at https://ddinter2.scbdd.com.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, P.R. China.
- School of Computer Science, National University of Defense Technology, Changsha, Hunan 410073, P.R. China.
- Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
ORCID-Profile: Yao Tian, Jiacai Yi, Chengkun Wu, Jinfu Peng, Dongsheng Cao
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Hunan Provincial Science Fund for Distinguished Young Scholars
- Science and Technology Innovation Program of Hunan Province
- Natural Science Foundation of Hunan Province
- Guangdong Provincial Science and Technology Innovation Strategy Special Fund
- HKBU Strategic Development Fund project
Zitieren
APA
Tian, Y., Yi, J., Wang, N., Wu, C., Peng, J., Liu, S., Yang, G., & Cao, D. (2025). DDInter 2.0: an enhanced drug interaction resource with expanded data coverage, new interaction types, and improved user interface. Nucleic Acids Research, 53(D1), D1356-D1362. https://doi.org/10.1093/nar/gkae726
Vancouver
Tian Y, Yi J, Wang N, Wu C, Peng J, Liu S, et al. DDInter 2.0: an enhanced drug interaction resource with expanded data coverage, new interaction types, and improved user interface. Nucleic Acids Research. 2025;53(D1):D1356-D1362. doi:10.1093/nar/gkae726
BibTeX
@article{Tian2025,
author = {Tian, Yao and Yi, Jiacai and Wang, Ningning and Wu, Chengkun and Peng, Jinfu and Liu, Shao and Yang, Guoping and Cao, Dongsheng},
title = {DDInter 2.0: an enhanced drug interaction resource with expanded data coverage, new interaction types, and improved user interface},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {D1},
pages = {D1356--D1362},
doi = {10.1093/nar/gkae726}
}
EUVIMED